Skip to main content

NATIXIS ADVISORS, LLC

Position in TEVA — Teva Pharmaceutical Industries Ltd

CIK 1018331 Boston, MA

Position in TEVA

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$19,229,779
+$2,186,016 QoQ
Shares Held
567,585
+0.3% QoQ
Ownership
0.049%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#104
of 671 holders
Holding Since
Mar 2024
10 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in TEVA Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

NATIXIS ADVISORS, LLC holds $144,607,995 across 17 Drug Manufacturers - Specialty & Generic names. TEVA ranks #2 (13.3% of the industry book) .

# Ticker Company Shares Value (USD) Open
2 TEVA
Teva Pharmaceutical Industries Ltd
This page
567,585 $19,229,779

All Filings in TEVA

Export CSV
10 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $19,229,779 567,585
2026-03-31 $17,043,763 565,862
2025-12-31 $9,122,839 292,305
2025-09-30 $5,528,719 273,699
2025-06-30 $6,456,203 385,215
2025-03-31 $5,117,026 332,923
2024-12-31 $11,119,929 504,534
2024-09-30 $3,042,983 168,867
2024-06-30 $3,271,970 201,352
2024-03-31 $2,229,083 157,979